Adapt Produtos Oftalmológicos Ltda
🇧🇷Brazil
- Country
- 🇧🇷Brazil
- Ownership
- Private
- Established
- 1993-01-01
- Employees
- 51
- Market Cap
- -
- Website
- https://adaptltda.com.br
Clinical Trials
5
Active:0
Completed:0
Trial Phases
1 Phases
Phase 3:5
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
Phase 3
5 (100.0%)Latanoprost/Brinzolamide BID Versus Latanoprost BID in Patients With OAG or OH
Phase 3
Withdrawn
- Conditions
- Ocular HypertensionOpen Angle Glaucoma
- Interventions
- Drug: Latanoprost+Brinzolamide combination
- First Posted Date
- 2012-11-06
- Last Posted Date
- 2014-12-11
- Lead Sponsor
- Adapt Produtos Oftalmológicos Ltda.
- Registration Number
- NCT01721707
- Locations
- 🇧🇷
Department of Ophthalmology / Hospital São Paulo, São Paulo, Brazil
Antibiotic Steroid Combination Compared With Individual Administration in the in the Treatment of Ocular Inflammation and Infection
Phase 3
Withdrawn
- Conditions
- Infection Associated BlepharitisConjunctivitis, BacterialOcular InflammationKeratitis
- Interventions
- First Posted Date
- 2012-11-06
- Last Posted Date
- 2014-12-11
- Lead Sponsor
- Adapt Produtos Oftalmológicos Ltda.
- Registration Number
- NCT01721694
- Locations
- 🇧🇷
Department of Ophthalmology of Hospital São Paulo, São Paulo, Brazil
Efficacy of Moxifloxacin/Prednisolone in Prevention of Post Surgery Inflammation
Phase 3
- Conditions
- Eye Infection/Inflammation Other
- Interventions
- Drug: moxifloxacin/prednisolone combination
- First Posted Date
- 2012-05-22
- Last Posted Date
- 2012-05-22
- Lead Sponsor
- Adapt Produtos Oftalmológicos Ltda.
- Target Recruit Count
- 66
- Registration Number
- NCT01603030
- Locations
- 🇧🇷
Universidade Federal de São Paulo - Hospital São Paulo - UNIFESP, São Paulo, SP/Brazil, Brazil
Evaluate the Use of Ganciclovir Gel 0.3% for the Treatment of Conjunctivitis Caused by Adenovirus
Phase 3
- Conditions
- ConjunctivitisAdenovirus.
- Interventions
- Drug: Ophthalmic gel (placebo)
- First Posted Date
- 2012-05-17
- Last Posted Date
- 2012-05-17
- Lead Sponsor
- Adapt Produtos Oftalmológicos Ltda.
- Target Recruit Count
- 22
- Registration Number
- NCT01600365
Evaluation of Efficacy and Safety of Susanna Implant in Patients With Refractory Glaucoma.
Phase 3
- Conditions
- Glaucoma
- First Posted Date
- 2011-03-14
- Last Posted Date
- 2011-05-10
- Lead Sponsor
- Adapt Produtos Oftalmológicos Ltda.
- Target Recruit Count
- 76
- Registration Number
- NCT01314170
- Locations
- 🇧🇷
Hospital Israelita Albert Einstein, São Paulo, Brazil
News
No news found